T1	Participants 42 102	patients with atrial fibrillation undergoing cardiac surgery
T2	Participants 409 426	multicentre trial
T3	Participants 428 477	One hundred and fifty patients with documented AF
T4	Participants 548 629	One hundred and thirty-two patients were included in the cost-effectiveness study
